Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5152| Title: | Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation | Authors: | Weppler, Alison M Da Meda, Laetitia Pires da Silva, Ines Xu, Wen Grignani, Giovanni Menzies, Alexander M Carlino, Matteo S Long, Georgina V Lo, Serigne N Nordman, Ina Steer, Christopher B Lyle, Megan Trojaniello, Claudia Ascierto, Paolo A Lebbe, Celeste Sandhu, Shahneen |
Issue Date: | 2023 | Source: | Weppler, A. M., Da Meda, L., Pires da Silva, I., Xu, W., Grignani, G., Menzies, A. M., Carlino, M. S., Long, G. V., Lo, S. N., Nordman, I., Steer, C. B., Lyle, M., Trojaniello, C., Ascierto, P. A., Lebbe, C., & Sandhu, S. (2023). Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation. European journal of cancer (Oxford, England : 1990), 183, 109–118. https://doi.org/10.1016/j.ejca.2023.01.016 | Journal: | European journal of cancer (Oxford, England : 1990) | Abstract: | Metastatic Merkel cell carcinoma (mMCC) is highly responsive to immune checkpoint inhibitors (ICIs); however, durability of response after treatment cessation and response to retreatment in the setting of progression is unknown. | Description: | Cairns & Hinterland Hospital and Health Service (CHHHS) affiliated authors: Christopher B Steer, Megan Lyle | DOI: | 10.1016/j.ejca.2023.01.016 | Keywords: | Durability of response;Immune checkpoint inhibitors;Merkel cell carcinoma;Retreatment;Treatment cessation | Type: | Article |
| Appears in Sites: | Cairns & Hinterland HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.